GE HealthCare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies
New data supports the potential role of Artificial Intelligence (AI) in predicting patients’ response to immunotherapies in advance of their treatment. AI models demonstrated 70 to 80 percent accuracy in predicting both the likelihood of efficacious response a

